Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Science

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2010.01807.xPMID 21205068PMCID PMC11158250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on treatment of uterine sarcoma

  2010cited by this paper
• Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease.

  2010cited by this paper
• Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth

  2010cited by this paper
• The effect of ultrasound on angiogenesis: an in vivo study using the chick chorioallantoic membrane.

  2009cited by this paper
• Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis

  2009cited by this paper
• Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

  2008cited by this paper
• Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib

  2008cited by this paper
• A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

  2008cited by this paper
• Antitumor effect of TNP‐470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound

  2007cited by this paper
• Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.

  2007cited by this paper
• Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.

  2007cited by this paper
• Low-intensity ultrasound induces angiogenesis in rat hind-limb ischemia.

  2006cited by this paper
• Rare uterine cancers.

  2005cited by this paper
• Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity

  2005cited by this paper
• Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells

  2005cited by this paper
• Healing sound: the use of ultrasound in drug delivery and other therapeutic applications

  2005cited by this paper
• Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.

  2004cited by this paper
• The anti-angiogenic basis of metronomic chemotherapy

  2004cited by this paper
• Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.

  2004cited by this paper
• Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

  2003cited by this paper
• Power Doppler Assessment of Vascular Changes During Fracture Treatment With Low‐Intensity Ultrasound

  2003cited by this paper
• Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

  2003cited by this paper
• Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.

  2002cited by this paper
• Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy

  2002cited by this paper
• Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

  2002cited by this paper
• Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

  2001cited by this paper
• Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

  2000cited by this paper
• Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model.

  1999cited by this paper
• Characteristics of rhabdomyosarcoma cell lines derived from uterine carcinosarcomas

  1997cited by this paper
• Interaction of ultrasound with neoplastic tissue. II. Systemic effects after local sonic irradiation.

  1976cited by this paper
• Interaction of ultrasound with neoplastic tissue. Local effect on subcutaneously implanted Furth-Columbia rat Wilms' tumor.

  1975cited by this paper
• Obstetrics and Gynecology

  1917cited by this paper

• Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues

  2020cites this paper
• A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment

  2018influential citation
• In Vitro Carcinoma Treatment Using Magnetic Nanocarriers under Ultrasound and Magnetic Fields

  2018cites this paper
• Therapeutic Effect of Radiotherapy in Breast Cancer Cells Ultrasound and Microbubbles Combined with Gold Nanoparticles Enhanced the Therapeutic Effect of Radiotherapy in Breast Cancer Cells

  2015cites this paper
• Azaspirene analogs inhibit the growth of human uterine carcinosarcoma in vitro and in vivo.

  2015cites this paper
• Development of a Cancer Treatment with the Concomitant Use of Low-Intensity Ultrasound: Entering the Age of Simultaneous Diagnosis and Treatment

  2014influential citation
• Irinotecan delivery by microbubble-assisted ultrasound: in vitro validation and a pilot preclinical study.

  2013cites this paper
• The use of nanoparticulate delivery systems in metronomic chemotherapy.

  2013cites this paper
• Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model.

  2013cites this paper
• Development of a Cancer Treatment with Low-Intensity Ultrasound

  2013cites this paper
• Low-Intensity Ultrasound Irradiation for Human Cancer -A New Therapeutic Application-

  2012cites this paper
• Metronomic therapy for gynecologic cancers.

  2012cites this paper
• Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.

  2011cites this paper
• A phase II study of low-dose protracted irinotecan in patients with advanced sarcomas.

  2011cites this paper